Italy's stock exchange delivered the strongest half-year performance among major European bourses in 2026, with the FTSE MIB index jumping 15% and total market capitalization hitting a record €1.209 trillion. Yet beneath this headline success, the number of companies listed on Italian markets continues to shrink—a trend that raises questions about the long-term health of the nation's public equity ecosystem.
Why This Matters
• Record performance: Italy's main index outpaced Paris, Frankfurt, and Madrid in the first six months, marking the best European showing.
• Shrinking roster: The total number of listed companies fell to 416, with no initial public offerings on the main board and record net exits from the SME growth market.
• Investment implications: While existing shareholders celebrate gains, the disappearing pipeline of new listings signals potential trouble for future market diversity and depth.
Market Capitalization Surge Masks Structural Decline
Data released by Consob, Italy's securities regulator, paints a paradoxical picture. The FTSE MIB index closed the first half at levels not seen since the dot-com peak of March 2000, with supervised companies' aggregate market value up 12.3% from year-end 2025 and 27.3% year-over-year. Italian equities comfortably beat the Euro Stoxx 50, France's CAC 40 (+3.1%), Germany's DAX (+2.1%), and Spain's IBEX 35 (+12.5%).
Banking stocks led the charge, benefiting from stable net interest margins and generous dividend policies. The country's political stability—a rarity in recent European memory—compressed bond spreads and attracted foreign capital. Analysts point to valuations that remain discounted relative to eurozone averages: the FTSE Italia All Shares forward price-to-earnings ratio sits around 11.8, suggesting room for further appreciation.
Yet this rosy outlook coexists with a troubling contraction. According to Consob's mid-year Capital Markets report, Euronext Milan (the main board) recorded zero IPOs in the first half and saw a net reduction of three companies, dropping from 198 to 195. The smaller Euronext Growth Milan (EGM)—designed for high-potential SMEs—suffered an even steeper decline, losing eight names and falling from 211 to 203 listings. Including the Vorvel Equity Auction segment, the total count across all Italian markets slipped to 416.
Why Companies Are Leaving
The exodus is driven overwhelmingly by takeover bids. Over the past four years, more than 65% of delistings resulted from public tender offers, and that pattern held in early 2026—67% of exits came via buyouts, with another 7% attributable to mergers. Private equity firms and industrial acquirers view undervalued mid-caps as attractive targets, especially when share prices trade below intrinsic value.
Other factors compound the flight from public markets:
• Compliance costs: Maintaining a listing requires ongoing regulatory filings, independent audits, and investor relations infrastructure. For smaller firms, these expenses can outweigh the benefits of access to public capital.
• Liquidity shortfalls: Many EGM-listed companies struggle to generate meaningful daily trading volumes, limiting price discovery and making shares less attractive to institutional investors.
• Private capital allure: Venture capital and buyout funds offer flexible financing without the scrutiny and quarterly earnings pressures of public ownership. In an era when much tech and AI value creation happens behind closed doors, staying private has become the default for high-growth startups.
• Governance flexibility: Delisting allows founding families and management teams to pursue long-term strategies without facing shareholder activism or the risk of hostile bids.
Since 2023, Euronext Milan has seen only four IPOs, and exits have systematically exceeded new admissions. The trend reflects a broader shift in global finance: an increasing share of capital raising now occurs outside regulated exchanges, particularly in sectors like artificial intelligence, semiconductors, and biotech.
Impact on Residents and Retail Investors
For everyday Italians with brokerage accounts or pension allocations to domestic equities, the narrowing market presents both opportunities and risks. On the upside, concentration in large, profitable banks and industrials has fueled index gains and dividend income. Savers who held diversified positions in Italian stocks enjoyed strong returns through mid-2026, outperforming bond yields and most eurozone peers.
The downside lies in reduced choice and diversification. A shrinking universe of listed companies means fewer sector exposures and less opportunity to invest in early-stage growth stories. Retail investors seeking exposure to innovative SMEs may find themselves priced out by private funds or forced to accept higher minimum investments. Additionally, a thinner market can amplify volatility—when fewer names dominate the index, idiosyncratic shocks at individual companies carry outsized weight.
Tax considerations also matter. Gains on Italian equities held in standard brokerage accounts face a 26% capital gains levy, while dividends from domestic companies benefit from favorable withholding treatment. The absence of new IPOs means retail savers miss out on potential "pop" returns that often accompany debuts, a phenomenon more common in London, Amsterdam, and New York.
Policy Response and the Stalled Capital Markets Decree
Recognizing the structural headwinds, Rome passed the so-called Decreto Capitali (Capital Markets Decree) with the aim of jumpstarting listings. The legislation included incentives for IPOs, streamlined disclosure rules for smaller issuers, and enhanced governance standards for EGM companies. Yet implementation has lagged. The government extended implementation deadlines until March 2026, and many substantive reforms remain on paper rather than in practice.
Observers note that regulatory fixes alone cannot overcome macroeconomic uncertainty. Geopolitical tensions—from energy security to trade disputes—continue to rattle investor confidence. Central bank policy, while supportive, has yet to fully normalize after years of emergency stimulus. In this environment, company founders and boards weigh the certainty of a private buyout against the unpredictability of public market reception.
Consob itself has signaled concern, noting in its semi-annual bulletin that the absence of fresh blood undermines market depth and dynamism. Without a pipeline of new entrants, the exchange risks becoming a static club of legacy industrials and banks, less able to channel savings toward emerging sectors.
What Comes Next
Forecasts for the remainder of 2026 and into 2027 remain cautiously optimistic. Equity strategists expect the FTSE MIB to climb a further 8% to 13%, supported by projected earnings growth of 16% in 2026 and 11% in 2027. Intesa Sanpaolo places a year-end 2027 target of 54,500 points on the index, implying roughly 9% upside from current levels. Sectors drawing investor interest include automotive suppliers, consumer discretionary, telecommunications infrastructure, energy efficiency, semiconductors, luxury goods, and artificial intelligence applications.
Yet selectivity is the watchword. After three consecutive years of double-digit gains, market participants warn that not all shares will participate equally. Utilities face modest growth prospects, while pharmaceuticals grapple with innovation slowdowns. The recent underperformance of cyclical consumer names—particularly autos and luxury—has already dented broader returns in 2026's opening months.
For the listing pipeline, a turnaround hinges on several factors: a sustained drop in Italy's sovereign risk premium, clarity on eurozone monetary policy, and tangible incentives from the capital markets decree. If bond spreads continue to narrow and political continuity holds, some advisers believe 2027 could see a modest revival of IPO activity. But structural competition from private markets is unlikely to abate, meaning any rebound will be gradual.
Lessons for Long-Term Investors
Residents building wealth through Italian equities should approach the current environment with both confidence and caution. The index's outperformance demonstrates that homegrown companies can compete on a European stage, and favorable valuations suggest the rally has room to run. At the same time, a dwindling roster of listed names limits diversification and concentrates risk.
Practical steps include maintaining a balanced allocation across sectors, monitoring earnings announcements from large-cap banks and industrials, and staying alert to delisting news that can trigger sudden price moves. Those interested in SME growth stories may need to explore private placements or wait for policy reforms to bear fruit. Above all, the dual narrative of record prices and shrinking breadth underscores the importance of looking beyond headline index numbers to understand the market's true health.
